I agree that this site is using cookies. You can find further informations here.
X
Hofsess, Scott
30  results:
Search for persons X
?
1

Antibody–Drug Conjugate Sacituzumab Govitecan Drives Effici..:

Kopp, Anna ; Hofsess, Scott ; Cardillo, Thomas M....
Molecular Cancer Therapeutics.  22 (2022)  1 - p. 102-111 , 2022
Link: https://doi.org/10.1158/..
 
?
2

Benzyl vinylogous amide substituted aryldihydropyridazinone..:

Edmondson, Scott D. ; Mastracchio, Anthony ; He, Jiafang...
Bioorganic & Medicinal Chemistry Letters.  13 (2003)  22 - p. 3983-3987 , 2003
Link: https://doi.org/10.1016/..
 
?
3

Design and Synthesis of Potent, Selective, and Orally Bioav..:

Liverton, Nigel J. ; Butcher, John W. ; Claiborne, Christopher F....
Journal of Medicinal Chemistry.  42 (1999)  12 - p. 2180-2190 , 1999
Link: https://doi.org/10.1021/..
 
?
4

Final Results From the Randomized Phase III ASCENT Clinical..:

Tolaney, Sara ; Loirat, Delphine ; Punie, Kevin...
qt3271x9mg.  , 2024
Link: https://escholarship.org..
 
?
5

Figure S10 from Improving Intracellular Delivery of an Anti..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
doi:10.1158/1535-7163.25338070.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
6

Supplementary Methods from Improving Intracellular Delivery..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
https://figshare.com/articles/journal_contribution/Supplementary_Methods_from_Improving_Intracellular_Delivery_of_an_Antibody_Drug_Conjugate_Targeting_Carcinoembryonic_Antigen_Increases_Efficacy_at_Clinically_Relevant_Doses_i_In_Vivo_i_/25338040.  , 2024
Link: https://doi.org/10.1158/..
 
?
7

Figure S4 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
https://figshare.com/articles/journal_contribution/Figure_S4_from_Improving_Intracellular_Delivery_of_an_Antibody_Drug_Conjugate_Targeting_Carcinoembryonic_Antigen_Increases_Efficacy_at_Clinically_Relevant_Doses_i_In_Vivo_i_/25338061.  , 2024
Link: https://doi.org/10.1158/..
 
?
8

Figure S6 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
doi:10.1158/1535-7163.25338055.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
9

Figure S3 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
doi:10.1158/1535-7163.25338064.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
10

Figure S7 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
https://figshare.com/articles/journal_contribution/Figure_S7_from_Improving_Intracellular_Delivery_of_an_Antibody_Drug_Conjugate_Targeting_Carcinoembryonic_Antigen_Increases_Efficacy_at_Clinically_Relevant_Doses_i_In_Vivo_i_/25338052.  , 2024
Link: https://doi.org/10.1158/..
 
?
11

Figure S8 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
https://figshare.com/articles/journal_contribution/Figure_S8_from_Improving_Intracellular_Delivery_of_an_Antibody_Drug_Conjugate_Targeting_Carcinoembryonic_Antigen_Increases_Efficacy_at_Clinically_Relevant_Doses_i_In_Vivo_i_/25338046.  , 2024
Link: https://doi.org/10.1158/..
 
?
12

Figure S2 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
https://figshare.com/articles/journal_contribution/Figure_S2_from_Improving_Intracellular_Delivery_of_an_Antibody_Drug_Conjugate_Targeting_Carcinoembryonic_Antigen_Increases_Efficacy_at_Clinically_Relevant_Doses_i_In_Vivo_i_/25338067.  , 2024
Link: https://doi.org/10.1158/..
 
?
13

Figure S9 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
doi:10.1158/1535-7163.25338043.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
14

Figure S7 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
doi:10.1158/1535-7163.25338052.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
15

Figure S4 from Improving Intracellular Delivery of an Antib..:

Ian Nessler ; Baron Rubahamya ; Anna Kopp...
doi:10.1158/1535-7163.25338061.v1.  , 2024
Link: https://doi.org/10.1158/..
 
1-15